A cationic polymer drives glycosaminoglycan assembly and secretion for preclinical osteoarthritis therapy
{{output}}
Osteoarthritis (OA) affects nearly 500 million people worldwide and is characterized by an irreversible loss of glycosaminoglycans (GAGs) at articular cartilage surfaces, which are essential in maintaining cartilage mechanical properties and chondrocyte phenot... ...